Bizarre Patents
Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120045394 | HUMAN AND MOUSE TARGETING PEPTIDES IDENTIFIED BY PHAGE DISPLAY The present invention concerns methods and compositions for in vivo and in vitro targeting. A large number of targeting peptides directed towards human organs, tissues or cell types are disclosed. The peptides are of use for targeted delivery of therapeutic agents, incl... | 02/23/2012 |
| 20120039939 | COMPOSITIONS AND METHODS FOR VACCINE AND VIRUS PRODUCTION The present invention features methods of producing immunogenic compositions and viruses, methods of treating and preventing viral infection, and methods of producing an immune response using cells that express a polypeptide selected from the group consisting of: cdk13,... | 02/16/2012 |
| 20120034621 | MICROORGANISM CONCENTRATION PROCESS AND DEVICE A process for capturing or concentrating microorganisms for detection or assay comprises (a) providing a concentration device comprising a sintered porous polymer matrix comprising at least one concentration agent that comprises an amorphous metal silicate and that has ... | 02/09/2012 |
| 20120034265 | INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.... | 02/09/2012 |
| 20120028357 | AAV VECTORS PRODUCED IN INSECT CELLS The present invention relates to the production of adeno-associated viral vectors in insect cells. The insect cells therefore comprise a first nucleotide sequence encoding the adeno-associated virus (AAV) capsid proteins, whereby the initiation codon for translation of ... | 02/02/2012 |
| 20120020997 | MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS Vectors and methods for the production of influenza viruses suitable as recombinant influenza vaccines in cell culture are provided. Bi-directional expression vectors for use in a multi-plasmid influenza virus expression system are provided.... | 01/26/2012 |
| 20120018313 | NOVEL BIOTRACERS AND USES THEREOF FOR CONTROLLING FILTRATION PLANTS The present invention relates to novel biotracers, to a method for preparing same, and to a method for detecting the biotracers and for monitoring filtration systems.... | 01/26/2012 |
| 20120021403 | Human Endogenous Retrovirus with Foamy-Like Properties and Uses Thereof The invention relates to the discovery of a human endogenous retrovirus (HERV) family, Type I HERV-K (HML-2) which appear to be active in vitro and in vivo, infectious, and which have the have the salient features and properties of foamy retroviruses. Based on its natur... | 01/26/2012 |
| 20120015425 | Cellular Permissivity Factor for Viruses and Uses Thereof The present invention provides methods and compositions related to the generation of host cells permissive for virus growth, particularly Porcine Reproductive and Respiratory Syndrome (PRRS) virus.... | 01/19/2012 |
| 20120009624 | PROTEIN PARTICLES The invention relates to a protein particle comprising chimeric protein having an aggregating part capable of forming or aggregating into a substantially insoluble protein particle when expressed by a cell; and a functional part capable of binding to, or being bound by,... | 01/12/2012 |
| 20120003626 | SAMPLING DEVICES AND METHODS FOR CONCENTRATING MICROORGANISMS The present disclosure describes methods for concentrating microorganisms with concentration agents in a sampling device and the sampling device described herein. More specifically, methods for concentrating microorganisms from large volume samples with concentration ag... | 01/05/2012 |
| 20120003691 | METHOD OF ISOLATION AND PURIFICATION OF TRYPSIN FROM PRONASE PROTEASE AND USE THEREOF The present invention provides methods of isolation and purification of Streptomyces griseus trypsin (SGT) from PRONASE protease mixture in a single affinity chromatography step and uses of the purified SGT.... | 01/05/2012 |
| 20120003266 | VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE The invention features compositions and methods for the prevention or treatment of one or more strains of Chikungunya virus, as well as other alphavirus-mediated diseases.... | 01/05/2012 |
| 20110318814 | METHODS, KITS AND SYSTEMS FOR PROCESSING SAMPLES A method for isolating microorganisms from a sample, the sample including sample matrix and microorganisms, the method including the steps of providing a receptacle, the receptacle configured to allow filtering of the sample and to reversibly contain the sample and a co... | 12/29/2011 |
| 20110312060 | PURIFICATION OF VACCINIA VIRUS- AND RECOMBINANT VACCINIA VIRUS-BASED VACCINES The present invention relates to methods for purification of Vaccinia viruses (VV) and/or Vaccinia virus (VV) particles, which can lead to highly pure and stable virus preparations of predominantly biologically active viruses. The invention encompasses purifying a virus... | 12/22/2011 |
| 20110306114 | PURIFICATION OF VACCINIA VIRUSES USING HYDROPHOBIC INTERACTION CHROMATOGRAPHY The present invention relates to methods for purification of Vaccinia viruses (VV) and/or Vaccinia virus (VV) particles, which can lead to highly pure and stable virus preparations of predominantly biologically active viruses. The invention encompasses purifying a virus... | 12/15/2011 |
| 20110306113 | Scalable Process for Protein Purification The invention provides a process for the purification recombinantly expressed, self-assembled VLP from the homogenate of a bacterial host, wherein the process can be scaled up to a commercial production scale in a cost effective manner. The process comprises a first chr... | 12/15/2011 |
| 20110300603 | Tagged Ligands for Enrichment of Rare Analytes from a Mixed Sample Method of enriching specific cells from cellular samples are disclosed, comprising contacting in solution a cellular sample with affinity-tagged ligands (ATLs) each comprising a first ligand linked to an affinity tag, wherein the ligand selectively binds a cellular mark... | 12/08/2011 |
| 20110300181 | PURIFICATION OF VACCINIA VIRUS- AND RECOMBINANT VACCINIA VIRUS-BASED VACCINES The present invention relates to methods for purification of Vaccinia viruses (W) and/or Vaccinia virus (W) particles, which can lead to highly pure and stable virus preparations of predominantly biologically active viruses. The invention encompasses purifying a virus p... | 12/08/2011 |
| 20110293660 | NOVEL METHOD The present invention relates to a method for purifying a virus, or a viral antigen thereof, comprising at least the following steps: a) obtaining a fluid comprising the virus, or a viral antigen thereof, and b) purifying the fluid by at least one density gradient ultra... | 12/01/2011 |
| 20110287044 | RECOMBINANT CLASSICAL SWINE FEVER VIRUS (CSFV) COMPRISING A MODIFIED E2 PROTEIN AND METHODS FOR GENERATING SAID RECOMBINANT CSFV The invention relates to a recombinant classical swine fever virus (CSFV). A preferred recombinant CSFV comprises a deletion of at least one amino acid in a “TAVSPTTLR” domain of the E2 protein. The invention further relates to a vaccine comprising the recombinant C... | 11/24/2011 |
| 20110281329 | PROCESS AND SYSTEM FOR THE INDUSTRIAL SCALE PURIFICATION OF BACTERIOPHAGES INTENDED FOR BACTERIOPHAGE THERAPY The present invention is directed towards bacteriophage therapy, the treatment of infectious diseases, caused by pathogenic bacteria, using specific bacteriophages. The purity of bacteriophage preparations has been a major obstacle for their therapeutic use in the past.... | 11/17/2011 |
| 20110269116 | Cell Line From Rousettus As Host Cell For Pathogen Amplification The present invention relates to permanent cell lines from chiropterans suitable for amplification and production microbial agents, preferably viruses, and its use for diagnostic or therapeutic purposes.... | 11/03/2011 |
| 20110256576 | RECOVERY AND DETECTION OF MICROORGANISMS FROM MIXED CELLULOSE ESTER FILTRATION SUPPORTS BY SEQUENTIAL TREATMENT WITH METHANOL AND ACETONE The present invention is directed to the recovery of bacteria and microparasites, particularly Cryptosporidium and Giardia, from water samples by filtration through a mixed cellulose ester membrane, partial dissolution of said membrane with methanol follow... | 10/20/2011 |
| 20110256525 | COMPOSITIONS AND METHODS FOR PURIFYING AND CRYSTALLIZING MOLECULES OF INTEREST A composition-of-matter is provided. The composition comprising at least one antibody binding moiety capable of binding an antibody-labeled target molecule, cell or virus of interest, said at least one antibody binding moiety being attached to at least one coordinating ... | 10/20/2011 |
| 20110243986 | POLYNUCLEOTIDES ALLOWING THE EXPRESSION AND SECRETION OF RECOMBINANT PSEUDO-VIRUS CONTAINING FOREIGN EPITOPES, THEIR PRODUCTION, AND USE This invention provides a new approach to the design of a virus with a defective replication cycle, which can be rescued by wild type virus co-infection, and which expresses foreign antigenic epitopes that contribute to the elimination of virus infected cells and then t... | 10/06/2011 |
| 20110229957 | POLYMER-MEDIATED ELECTROMAGNETIC FIELD-BASED PARTICLE CONCENTRATOR There remains an unmet need for methods to efficiently concentrate and isolate small particles, such as nano-sized and micron-sized particles. The methods herein provide means to fulfill this need through the combination of two independent particle-concentrating mechani... | 09/22/2011 |
| 20110229971 | RECOMBINANT VIRUS PRODUCTION USING MAMMALIAN CELLS IN SUSPENSION The invention generally provides methods for producing recombinant AAV viral particles using cells grown in suspension. The invention provides recombinant AAV particles for use in methods for delivering genes encoding therapeutic proteins, and methods for using the reco... | 09/22/2011 |
| 20110217757 | MODIFIED VACCINIA ANKARA VIRUS VARIANT AND CULTIVATION METHOD The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus and characterized by the loss of its capability to reproductively replicate in human cell lines. It further describes recombinant viruses derived from this virus and... | 09/08/2011 |
| 20110217330 | NOVEL METHOD The present invention relates to a method for degrading host cell nucleic acids associated with a virus or a viral antigen thereof produced by cell culture, the method comprising at least two steps of nucleic acids degradation with a compound selected from i) an endonuc... | 09/08/2011 |
| 20110207202 | METHOD FOR THE PRODUCTION OF ADENOVIRAL VECTORS The invention provides methods for large-scale production of recombinant adenovirus 35, using perfusion systems and infection at very high-cell densities.... | 08/25/2011 |
| 20110201078 | LIGAND FUNCTIONALIZED POLYMERS Ligand functionalized substrates, methods of making ligand functionalized substrates, and methods of using functionalized substrates are disclosed.... | 08/18/2011 |
| 20110182932 | MODIFIED VACCINIA ANKARA VIRUS VARIANT The present invention provides an attenuated virus, which is derived from Modified Vaccinia Ankara virus, wherein the MVA-BN virus, or a derivative thereof, induces at least substantially the same level of immunity in vaccinia virus prime/vaccina virus boost regimes whe... | 07/28/2011 |
| 20110165224 | VACCINES FOR INCLUSION BODY HEPATITIS A composition comprising an isolated fowl adenovirus (FAdV), wherein the FAdV is a strain selected from FAdV-2, FAdV-7, FAdv-8a, FAdV-8b, FAdV-8a/8b or FAdV-11 serotype strains; and a suitable carrier and methods for inducing protective immunity in a subject and/or its ... | 07/07/2011 |
| 20110165645 | Methods Using Ion Exchange and Gel Filtration Chromatography for Poxvirus Purification Provided herein are methods for purifying poxviruses using one or more chromatographic steps including, but not limited to, gel filtration and/or ion exchange chromatography.... | 07/07/2011 |
| 20110151543 | CELL SEPARATION METHOD USING HYDROPHOBIC SOLID SUPPORTS Provided is a method of separating cells using a hydrophobic solid support. The method comprises contacting a solution containing cells with a hydrophobic solid support having a water contact angle between 70 and 90 degrees. By allowing cells to be adsorbed to the hydro... | 06/23/2011 |
| 20110142863 | FLOW THROUGH PURIFICATION PROCESSES FOR LARGE BIOMOLECULES The present invention relates, at least in part, to novel and improved flow-through purification processes for separating large biomolecules, such as, for example, encapsulated viruses, virus-like particles and conjugate vaccines from one or more contaminants in a sampl... | 06/16/2011 |
| 20110129446 | Clone of newcastle disease virus, its manufacture and its application in the medical treatment of cancer A new clone of Newcastle disease virus which is interferon insensitive and has an ICPI between 1.2 and 2.0 and which may be used in the treatment of cancer and other diseases.... | 06/02/2011 |
| 20110123559 | SWINE INFLUENZA HEMAGGLUTININ VARIANTS Polypeptides, polynucleotides, methods, compositions, and vaccines comprising influenza hemagglutinin and neuraminidase variants are provided.... | 05/26/2011 |
| 20110124086 | Hepatitis C Virus Culture System This disclosure provides compositions and methods for producing infectious hepatitis C virus (HCV). The produced HCV can be infectious in vivo and in vitro. In one aspect, the disclosure provides an immortalized primary hepatocyte transformed with a DNA construct compri... | 05/26/2011 |
